Evidence map›Paper›PMID 11120768›Full record

ArticleThe Journal of experimental medicine2000

Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other.

J Domen, I L Weissman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 217 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J DomenDepartment of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
I L Weissman
Stanford University · US

Funding

STEM CELL DETRMINATION GENES IN HSC AND HEMATOLYMPHOID CELLS IN MICEP01DK053074 · NIDDK · STANFORD UNIVERSITY · PI CLARKE, MICHAEL F · 1997 to 2007
$8.3M
NORMAL AND NEOPLASTIC LYMPHOCYTE MATURATIONR35CA042551 · NCI · STANFORD UNIVERSITY · PI WEISSMAN, IRVING LERNER · 1986 to 1999
–
NCI NIH HHS CA42551NIDDK NIH HHS P01 DK053074NIDDK NIH HHS P01DK53074
6 · The paper itself

Abstract

Growth factors can cause cells to proliferate, differentiate, survive, or die. Distinguishing between these responses is difficult in multicellular, multiparameter systems. Yet this is essential to understand the impact on cells like hematopoietic stem cells (HSCs), which have strict and still poorly understood growth factor requirements. Single cell plating in serum-free medium allows direct assessment of growth factor responses. The range of tested factors can be expanded if the cells are protected from growth factor deprivation-induced apoptosis. BCL-2 is overexpressed in HSCs of H2K-BCL-2 transgenic mice, protecting them from many apoptotic stimuli. The response of single wild-type and transgenic HSCs to stimulations with individual factors was tested. Surprisingly, we find that high level BCL-2 expression does not prevent rapid death under serum-free conditions, even though it does in the presence of serum. We also find that transgenic, but not wild-type cells, survive and proliferate rapidly in response to steel factor (Kit ligand). These studies show that two separate signals are necessary to prevent apoptosis in HSCs, and that Kit ligand by itself provides a strong proliferative stimulus to HSCs. However, the proliferative response does not result in self-renewal, but in differentiation to all known hematopoietic oligolineage progenitors.

Indexed as

AnimalsApoptosisCell CountCell DifferentiationCell DivisionCells, CulturedCell SizeCulture Media, Serum-FreeGene Expression RegulationHematopoietic Stem CellsHistocytochemistryInterleukin-3Mast CellsMiceMice, TransgenicPeritoneal CavityCulture Media, Serum-FreeInterleukin-3Proto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-kitStem Cell FactorThrombopoietin

Identifiers

PMID11120768
PMCPMC2213494
OpenAlexW2169746118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.